Join        Login             Stock Quote

RLJ Lodging Trust (RLJ) Buys Embassy Suites Boston/Waltham Hotel

 November 15, 2012 12:31 PM

(By Balaseshan) RLJ Lodging Trust (NYSE: RLJ) said it has purchased the 275-room Embassy Suites Boston/Waltham, through an off-market transaction, for $64.5 million, or about $235,000 per key.

The purchase price represents a forward capitalization rate of about 7.9 percent on the hotel's projected 2013 net operating income. The company purchased this asset with cash available on its balance sheet.

The acquisition of this premium-branded hotel is compliant with the company's overall investment thesis. With the addition of this new hotel, the company now owns 145 hotels with more than 21,600 rooms across 21 states and the District of Columbia.

[Related -RLJ Lodging Trust (RLJ) Opens Hotel Indigo New Orleans Garden District]

With more than 37 percent revenue per available room (RevPAR) growth already generated through September, the company expects that this hotel will continue to produce outsized returns due to its recent brand conversion and its prime location within this excellent market.

The hotel went through an extensive $12-million brand conversion from a DoubleTree Guest Suites to an Embassy Suites in 2011, one of only three Embassy Suites in the greater Boston area. During the conversion, the guest suites and the public spaces were also significantly upgraded.

The hotel's prime location in Boston's submarket of Waltham, provides the Hotel with a wide variety of demand generators. Additionally, the hotel's all-suite product is an attractive option to the more than 18 million leisure travelers that visit the greater Boston area annually.

[Related -This Stock Is Flying High With Another Dividend Increase]

RLJ is trading down 0.46 percent at $17.33 on Thursday. The stock has been trading between $15.28 and $19.75 for the past 52 weeks.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageSolar and Biotechnology Stocks Rally as Rational Exuberance Dominates

Solar stocks are rallying due to positive earnings and deals. Biotechnology stocks are also rallying due to read on...

article imageA Hefty Upside Surprise For February Payrolls

Private payrolls increased substantially more than expected in February, delivering an encouraging dose of read on...

article imageWarren Buffett’s Stellar Record In Defying Economic Gravity

One of the more intriguing observations in Berkshire Hathaway’s new letter to shareholders is Warren read on...

article imageDebate Around the 2015 Rate Hike Intensifies

Following Janet Yellen's Senate Banking Committee testimony, the Fed seems to be quite deliberate in read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.